Whooping Cough Vaccine– How is it Effective?
Summary: Whooping cough vaccine is used to induce immunity in the body, so that it can fight effectively against bacteria causing Pertussis. Whooping cough or Pertussis is observed mostly in children and infants, and is known to reduce the oxygen intake through severe cough.
Whooping cough vaccine was developed to protect children from the whooping cough disease or Pertussis. Whooping cough, which is caused by Bordetella Pertussis bacteria, lives in the throat section of the human body. The vaccine is used to induce immunity in the body to fight against the bacteria, but the effect of the vaccine is known to wear off after few years. There has been considerable rise in the cases of whooping cough in adults and adolescents.
Whooping cough vaccine is used to treat whooping cough effectively. Whooping cough derived its name from the whooping sound a person makes on taking a deep breath while coughing. The severity of this cough can lead to vomiting, and even death in few cases. It is better known to affect children and infants, making them breathless. Small babies are exposed to a heavy danger upon contacting whooping cough. This cough reduces the intake of oxygen, making the babies breathless and exposed to danger. Such babies are often incubated and put on ventilators until they are cured of the infection. There are cases, when the baby can cough out the tube due to the severity of the cough.
Whooping cough is highly infectious, and has the ability to spread from one person to another through air, or through tiny drops of fluid from the mouth or nose of the infected person. The chances of increased infection are during the early stages of the illness. Vaccine for Whooping cough, which is part of DTaP, is very effective to treat Pertussis. DTaP stands for diphtheria, tetanus, acellular pertussis immunization and is administered in five doses.
Whooping Cough Vaccine For Children
Pertussis has higher chances of affecting children with low immunity, between 11 to 18 years of age. Such children are given another form of whooping cough vaccine called Tdap, which combines vaccines for diphtheria and tetanus. This vaccine is administered when the child is 11 or 12 years of age. However, there are few exceptions and circumstances, which are to be considered while administering this vaccine.
Whooping cough or Pertussis can be identified and confirmed by a diagnosis, which includes the physical examination of throat and nose. In some cases, a blood test or an X-ray is also performed. Children affected with whooping cough are treated with whooping cough vaccine and hospitalized, if the cough persists. Infants and small children are at higher risk to develop pneumonia, and should be hospitalized to reduce the complications.